11.600
−0,85%
2026-10-19
Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -86.6% | -34.9% | 1 / 3 | -50.9% | +0.39 pp | -3.45 pp | +5.8% | 0.46 | 15.39 | 531 | −50,9% | 6,9 | −86,6% | 15.39 | 14.21 | +8,3% |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 11.600 (close price on 2026-10-19)EPS (TTM): 753,5
Financial charts
1.Revenue & growth
VND bn531Q2/26
1.Revenue & growth
VND bn531Q2/26
2.Profit & growth
VND bn13,5Q2/26
3.Profit mix (Penman)
VND bn115Q2/26
4.Margins & cost structure
%13.9%Q2/26
5.Returns & cash cycle
% · days5.5%Q2/26
6.Earnings quality & cash
VND bn-261Q2/26
7.Asset structure
VND bn2.587Q2/26
8.Funding & debt health
VND bn · times2.587Q2/26
9.Revenue backlog
VND bn1,11Q2/26
10.Valuation
times · %14,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %119Q2/26
Adjusted EPS growth, latest quarter
-73.7%
Average adjusted EPS growth, 3 quarters
-30.6%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26